Literature DB >> 16008516

Chinese herbal formula, Bing De Ling, enhances antitumor effects and ameliorates weight loss induced by 5-fluorouracil in the mouse CT26 tumor model.

Qing Xu1, Jeffrey G Brabham, Shumin Zhang, Pamela Munster, Karen Fields, Ruan-Jin Zhao, Hua Yu.   

Abstract

The use of complementary and alternative medicines-including a variety of herbal therapies-by patients undergoing cancer chemotherapy has been well documented. Despite such widespread use, however, the benefits and potential mechanisms of such herbal medicines remain largely anecdotal. In this study we examined the effects of a Chinese herbal formula, Bing De Ling, when administered as an adjunct to chemotherapeutic agent 5-fluorouracil (5-FU) in the CT26 mouse colon cancer model. 5-FU and Bing De Ling were administered to both nave and CT26 mouse colon cancer-bearing BALB/c mice. Our results indicate that although the herbal formula alone did not result in antitumor effects under experimental conditions, it significantly enhanced 5-FU-induced tumor growth inhibition. Oral administration of Bing De Ling also increased survival rates of both tumor-bearing and tumor-free mice treated with 5-FU. Furthermore, oral administration of Bing De Ling reduced weight loss in tumor-free mice receiving 5-FU when compared to tumor-free mice that received 5-FU alone. Our data further show that 5-FU upregulates serum levels of IL-6, known to contribute to weight loss, in tumor-free mice, and that this increase in IL-6 is significantly less in mice that received Bing De Ling in addition to 5-FU. These data show Bing De Ling both enhances the antitumor responses of 5-FU and ameliorates side effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008516     DOI: 10.1089/dna.2005.24.470

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  3 in total

1.  Association Between Use of Traditional Chinese Medicine Herbal Therapy and Survival Outcomes in Patients With Stage II and III Colorectal Cancer: A Multicenter Prospective Cohort Study.

Authors:  Yun Xu; Jun J Mao; Lingyun Sun; Lin Yang; Jie Li; Yingxu Hao; Huashan Li; Wei Hou; Yuping Chu; Yu Bai; Xiaoqiang Jia; Jinwan Wang; Lin Shen; Ying Zhang; Jianbin Wang; Jianping Liu; Yufei Yang
Journal:  J Natl Cancer Inst Monogr       Date:  2017-11-01

2.  Treatment of chemotherapy-induced cachexia with BST204: a multimodal validation study.

Authors:  Hyun Ju Yoo; Dong-Cheol Woo; Jeong Kon Kim; Ho-Jin Kim; Su Jung Kim; Chul-Woong Woo; Sang-Tae Kim; Minju Im; Sun Kyu Park; Jeom-Yong Kim
Journal:  Metabolomics       Date:  2021-03-18       Impact factor: 4.290

Review 3.  Phytochemicals Approach for Developing Cancer Immunotherapeutics.

Authors:  Shu-Yi Yin; Ning-Sun Yang; Tien-Jen Lin
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.